| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_08e26d590c0ecaa3b996625ba2d031b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3adbb58b71f70f2829c7acbe5b6650ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_74eaab766cc0e87736233bc4e66edd90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e9ff81c0bf925374ca3b4247b32533f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bba842fc4d37dfcaced1b55bc0c91c7c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-56 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-56 |
| filingDate |
2011-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c62cf0095bfa75a51630b6a6bdf9d5d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acc04898109fb315886507c9ed0f4674
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c8c5f61626c41d2d422d667dc1f15d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5aeaf5c0b61425cc544ce91c3808e231 |
| publicationDate |
2013-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2013137734-A1 |
| titleOfInvention |
Polymorphs of an Active Pharmaceutical Ingredient |
| abstract |
The present invention relates to crystalline form I of Febuxostat as well as to pharmaceutical compositions camprising crystalline form I as an active pharmaceutical ingredient. Furthermore the present invention relates to a further polymorphic form of Febuxostat designated as form II and to a novel solvate of Febuxostat. The present invention also relates to methods of making crystalline form I, form II and the novel solvate of Febuxostat. |
| priorityDate |
2010-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |